M Ventures
Edit

M Ventures

https://www.m-ventures.com
Last activity: 16.07.2023
Tags:PlatformTechnologyHealthTechDrugDevelopmentBioTechProductArtificial IntelligenceHumanIndustry
M Ventures is the strategic, corporate venture capital arm of Merck KGaA, Darmstadt, Germany. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘ KGaA, Darmstadt, Germany's core business areas. From our headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by great entrepreneurs. M Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. M Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck KGaA, Darmstadt, Germany's science and technology base.
News
51
Team
23
Portfolio
75
References
38
Location:Netherlands, North Holland, Amsterdam
Member count:11-50
Investment Type: Venture Capital
Investment Stage: Pre-Seed; Seed; Series A

News 51

DateTitleDescription
29.01.2022Future Fer...First company to develop an AI...
11.12.2021DNA Script...DNA Script, a leader in Enzyma...
11.12.2021AI Chip In...Keith Kressin appointed as new...
11.12.2021Altoida La...Research collaboration will id...
11.12.2021Merck KGaA...Merck KGaA, Darmstadt, Germany...
11.12.2021iOmx Thera...Martinsried / Munich, Germany,...
11.12.2021Altoida Aw...Breakthrough Designation will ...
11.12.2021DNA Script...New Funding, Targeted to Accel...
11.12.2021NanoSyrinx...NanoSyrinx has raised a furthe...
22.11.2021Xilio Ther...Xilio Therapeutics, Inc. today...
Show more

Team 23

DateNameDescription
18.02.2023Leonie Wil...Leonie Willemse joined the fun...
16.11.2022Tobias Egl...Tobias Egle, Analyst in the Te...
13.09.2022Oliver Har...Oliver Hardick, EngD, is Entre...
22.08.2022Ilja Aizen...Ilja Aizenberg (PhD, MBA) join...
13.07.2022Eyal Ben A...Eyal Ben Ami, PhD, MBA, joined...
05.05.2022Hakan Goke...Hakan Goker, PhD, is Managing ...
05.05.2022Owen Lozma...Dr Owen Lozman FRSC CChem CSci...
04.02.2022Javier Rod...Javier Rodriguez joined the Ve...
04.02.2022Nadiya Ish...Nadiya Ishnazarova, PhD, is an...
04.02.2022Daniel Fra...Daniel Franke, Principal in th...
Show more

Portfolio 75

DateNameWebsiteTotal RaisedLocation
14.04.2023ImmuneBrid...immunebrid...$12MUnited Sta...
12.03.2023Iktosiktos.ai$16.618865...France, Il...
21.02.2023Calypso Bi...calypsobio...$55.797665...Netherland...
18.02.2023Unisersunisers.ch$14MSwitzerlan...
08.11.2022Concerto B...concertobi...$47.541949...United Sta...
08.11.2022Hans Scham...galecto.co...$154.49846...Denmark, C...
08.11.2022Immunitas ...immunitast...$155MUnited Sta...
08.11.2022FoRx Thera...forxtherap...$12.111493...Switzerlan...
08.11.2022Pictor Lab...pictor-lab...--
08.11.2022Micropsi I...micropsi-i...$36.08MGermany, B...
Show more

Mentions in press and media 38

DateTitleDescriptionCategoryAuthorSource
03.05.2023Dutch-base...Leiden-based Anavo Therapeutic...funding n...Vishal Sin...siliconcan...
09.03.2023Iktos rais...French start-up Iktos has rais...-Fiona Alst...tech.eu/20...
17.02.2023Unisers se... Particle contamination durin...Financing-startuptic...
07.07.2022Tignis and...Introductions for Tignis and M...--einpresswi...
01.04.2022Additional... Swiss-US company Altoida is ...Financing-startuptic...
11.02.2022Blazing ne...Berlin-based Micropsi has rais...-Dan Taylortech.eu/20...
12.01.2022UCLA Spino...What You Should Know:-Syed Hamza...hitconsult...
11.12.2021Merck KGaA...Merck KGaA, Darmstadt, Germany...--m-ventures...
20.09.2021Clinical p...Calypso Biotech’s lead program...Financing ...-startuptic...
27.07.2021IoT Pionee...With Softbank’s Vision Fund 2 ...--africanews...
Show more